FL CARES: Cancer Drug Property Dataset

Larotrectinib US FDA Label

Compound: (3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide
Description: NA

Brand Name:
Code(s): LOXO-101
Approved:
Kinase Class: RY
Inhibitor Type: ?
Literature (PubMed): 0
Target(s): Neurotrophic receptor tyrosine kinase 1 , neurotrophic receptor tyrosine kinase 2 , Neurotrophic receptor tyrosine kinase 3
Disease(s):

International Nonproprietary Name: Larotrectinib [INN] (Source: PubChem)

KEGG Drug ID: D11137 (Source: PubChem)

USFDA Precision ID: UNII-PF9462I9HX (Source: PubChem)

US Adopted Name: LAROTRECTINIB [USAN] (Source: PubChem)

Sources: PubChem (4)